Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methadone, a full mu-opioid agonist, is the recommended treatment for opioid dependence during pregnancy. However, prenatal exposure to methadone is associated with a neonatal abstinence syndrome (NAS) characterized by central nervous system hyperirritability and autonomic nervous system dysfunction, which often requires medication and extended hospitalization. Buprenorphine, a partial mu-opioid agonist, is an alternative treatment for opioid dependence but has not been extensively studied in pregnancy. METHODS: We conducted a double-blind, double-dummy, flexible-dosing, randomized, controlled study in which buprenorphine and methadone were compared for use in the comprehensive care of 175 pregnant women with opioid dependency at eight international sites. Primary outcomes were the number of neonates requiring treatment for NAS, the peak NAS score, the total amount of morphine needed to treat NAS, the length of the hospital stay for neonates, and neonatal head circumference. RESULTS: Treatment was discontinued by 16 of the 89 women in the methadone group (18%) and 28 of the 86 women in the buprenorphine group (33%). A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group (with 58 exposed to buprenorphine and 73 exposed to methadone) showed that the former group required significantly less morphine (mean dose, 1.1 mg vs. 10.4 mg; P<0.0091), had a significantly shorter hospital stay (10.0 days vs. 17.5 days, P<0.0091), and had a significantly shorter duration of treatment for the neonatal abstinence syndrome (4.1 days vs. 9.9 days, P<0.003125) (P values calculated in accordance with prespecified thresholds for significance). There were no significant differences between groups in other primary or secondary outcomes or in the rates of maternal or neonatal adverse events. CONCLUSIONS: These results are consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women. (Funded by the National Institute on Drug Abuse; ClinicalTrials.gov number, NCT00271219.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the length, but not intensity, of neonatal abstinence syndrome and the neonates’ need for morphine relief was lower in women taking buprenorphine compared to methadone”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
The cited source says what the claim attributes to it.
In the citing paper
“there was lower retention in the buprenorphine treated group.”
From Maintenance Medication for Opiate Addiction: The Foundation of Recovery (2012) · cites this paper as [134]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intraclass correlations: Uses in assessing rater reliability.
Shrout, P. E., & Fleiss, J. L. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.2.420 · Cited by 24,532
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782 · cited 3×
“Eye, ear, nose, or throat problems 12 (14) 15 (17) 1 (1) 1 (2)”
A Comparison of Levomethadyl Acetate, Buprenorphine, and Methadone for Opioid Dependence
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431802 · Cited by 623
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
A Controlled Trial Comparing Buprenorphine and Methadone Maintenance in Opioid Dependence
Ling, W. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830050035005 · Cited by 366 · cited 4×
“Obstetrical problems 29 (33) 23 (27) 3 (4) 4 (7)”
InfluentialBuprenorphine suppresses heroin use by heroin addicts
Mello, N. K., & Mendelson, J. H. (1980) · Science · doi:10.1126/science.7352279 · Cited by 298
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Self-citationOPIOID DEPENDENCE DURING PREGNANCY
Kaltenbach, K., Berghella, V., & Finnegan, L. (1998) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70362-4 · Cited by 287
Self-citation
Research works printed but not linked: 4
- 10.1111/j.1360-0443.1997.tb02877.x · doi:10.1111/j.1360-0443.1997.tb02877.x · Paper page
- Mattick RP, 2009, Cochrane Database Syst Rev, 3, CD002209
- Finnegan LP, Kaltenbach K. Neonatal abstinence syndrome. In Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. 2nd ed. St. Louis: Mosby, 1992:1367-78.
- Mattick RP, 2008, Cochrane Database Syst Rev, 2, CD002207
Cited by
Items 601–700 of 1,000
Chanal, C., Mazurier, E., & Doray, B. (2022) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.13419 · Cited by 8
Levine, M., & O’Connor, A. D. (2012) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2012.08.008 · Cited by 7
Buprenorphine for Opioid Dependence
Gordon, A. J., & Krumm, M. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398338-1.00044-0 · Cited by 7
Medication-Assisted Treatment for Pregnant Women: An Interdisciplinary Group Based Model
Lander, L. R., Marshalek, P. J., & Sullivan, C. R. (2016) · Journal of Groups in Addiction & Recovery · doi:10.1080/1556035x.2016.1185987 · Cited by 7
Miller, J. S., & Anderson, J. G. (2021) · Journal for Specialists in Pediatric Nursing · doi:10.1111/jspn.12358 · Cited by 7
Bivin, B., Waring, A., & Alves, P. (2019) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000345 · Cited by 7
Rapid Buprenorphine Induction for Cancer Pain in Pregnancy
Irwin, M. N., Petersen, K. S., & Smith, M. A. (2020) · Journal of Palliative Medicine · doi:10.1089/jpm.2020.0524 · Cited by 7
An Amplitude-Integrated EEG Evaluation of Neonatal Opioid Withdrawal Syndrome
Lust, C. E., Vesoulis, Z. A., Zempel, J. M., Gu, H., Lee, S., Rao, R., & Mathur, A. (2022) · American Journal of Perinatology · doi:10.1055/a-1877-9291 · Cited by 6
Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome
Tobacyk, J., Parks, B. J., Salazar, P., Coward, L. U., Berquist, M. D., Gorman, G. S., & Brents, L. K. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110832 · Cited by 6
Implications of perinatal buprenorphine exposure on infant head circumference at birth
O’Connor, A. B., O’Brien, L. M., & Watson, L. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1599352 · Cited by 6
Martin, C. E., Scialli, A. C., & Terplan, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816569-0.00003-6 · Cited by 6
Timing of treatment for opioid use disorder among birthing people
Kim, K., Liu, G., Dick, A. W., Choi, S. W., Agbese, E., Corr, T. E., Hsuan, C., Wright, M. S., Park, S., Velott, D. L., et al. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209289 · Cited by 6
Oral Clonidine in the Management of Acquired Opioid Dependency
Beaulieu, M. J. (2013) · Neonatal Network The Journal of Neonatal Nursing · doi:10.1891/0730-0832.32.6.419 · Cited by 6
Périnatalité en cas d’addictions
Courty, P., & Nacache, L. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.07.034 · Cited by 6
Kinsella, M., Capel, Y., Nelson, S. M., & Kearns, R. J. (2022) · Journal of Substance Use · doi:10.1080/14659891.2022.2106600 · Cited by 6
Opioids and Opiates: Pharmacology, Abuse, and Addiction
Cruz, S. L., & Granados‐Soto, V. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6434-1_156-1 · Cited by 6
No 349 – Consommation de substances psychoactives pendant la grossesse
Ordean, A., Wong, S., & Graves, L. E. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.06.026 · Cited by 6
Maternal buprenorphine treatment during pregnancy and maternal physiology
Jansson, L. M., Vélez, M. L., McConnell, K., Milio, L. A., Spencer, N., Jones, H. E., & DiPietro, J. A. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.03.018 · Cited by 6
Self-citationBrennan, J., Wiedeman, C., Dunn, J. R., Schaffner, W., & Jones, T. F. (2019) · Public Health Reports · doi:10.1177/0033354919867718 · Cited by 6
Assessment of the newborn prenatally exposed to drugs: The history
Kaltenbach, K. A. (2019) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2019.01.008 · Cited by 6
Self-citationCarlo, W. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0755-7.00100-7 · Cited by 6
Drugs during Pregnancy and Lactation: New Solutions to Serious Challenges
Koren, G., Clark, S. M., & Matsui, D. M. (2012) · Obstetrics and Gynecology International · doi:10.1155/2012/206179 · Cited by 6
Chokshi, R. P., Parish, S., Santiago-Aponte, N. M., Ural, S., & O’Brien, J. M. (2024) · Medical Research Archives · doi:10.18103/mra.v12i8.5736 · Cited by 5
Coyle, M. G., Ounpraseuth, S., Lester, B. M., Dansereau, L. M., Hu, Z., & Laptook, A. R. (2024) · Journal of Perinatology · doi:10.1038/s41372-024-02144-6 · Cited by 5
Self-citationBeauman, S. S., Hu, Z., Rice, W. R., Devlin, L. A., Merhar, S. L., Fung, C. M., Brown, J., Osman, A., Pahl, A., Ramsey, K. W., et al. (2025) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2025.114859 · Cited by 5
Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder
O’Connor, A. B., & Bowling, N. (2020) · Journal of Correctional Health Care · doi:10.1177/1078345819897063 · Cited by 5
Beyond opioid prescribing: Evaluation of a substance use disorder curriculum for OBGYN residents
Martin, C. E., Thakkar, B., Cox, L., Johnson, E., Jones, H. E., & Connolly, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274563 · Cited by 5
Self-citationVella, A., Savona‐Ventura, C., & Mahmood, T. A. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2023.05.019 · Cited by 5
Buprenorphine-Naloxone Maintenance and Lactation
Jansson, L. M., McConnell, K., Vélez, M. L., Spencer, N., Gomonit, M. M., & Swortwood, M. J. (2023) · Journal of Human Lactation · doi:10.1177/08903344231209304 · Cited by 5
Anbalagan, S., Anderson, V., Favara, M. T., Stark, D., Carola, D. L., Solarin, K. O., Adeniyi-Jones, S. C., Kraft, W. K., & Aghai, Z. H. (2024) · Journal of Perinatology · doi:10.1038/s41372-024-02046-7 · Cited by 5
Mills-Huffnagle, S. L., Zawatsky, C. N., Bryant, G., Ebert, M. H., Augusto, C. M., Sipe, A., Horvath, N., & Nyland, J. E. (2024) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2024.107385 · Cited by 5
Brief review: Obstetric care and perioperative analgesic management of the addicted patient
Buckley, D. N., & Ibrahim, M. (2013) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-013-0084-7 · Cited by 5
Rana, D. B., McLeod, A. R., Gaston, P. K., Hill, D. M., & Pourcyrous, M. (2022) · Annals of Pharmacotherapy · doi:10.1177/10600280221134643 · Cited by 5
Longitudinal trends in meconium drug detection in 46 US states between the years 2015 and 2020
Pandya, V., Wilker, C., & Johnson‐Davis, K. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad024 · Cited by 5
Janganati, V., Salazar, P., Parks, B. J., Gorman, G. S., Prather, P. L., Peterson, E. C., Alund, A. W., Moran, J. H., Crooks, P. A., & Brents, L. K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1123261 · Cited by 5
Pharmacological Treatment of Substance Use Disorders
Srivastava, A. B., LEVIN, F. R., & Nunes, E. V. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_140-1 · Cited by 5
Methadone and neonatal abstinence syndrome (NAS): what we think we know, but do not
McCarthy, J. J., & Finnegan, L. P. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1316583 · Cited by 5
Low-dose buprenorphine initiation during pregnancy: a case report
Reddy, S., & Martin, C. E. (2024) · AJOG Global Reports · doi:10.1016/j.xagr.2024.100308 · Cited by 5
Taylor, M. G., Bauchat, J. R., Sorabella, L. L., Wanderer, J. P., Feng, X., Shotwell, M. S., & Ende, H. B. (2024) · Journal of Anesthesia · doi:10.1007/s00540-024-03314-8 · Cited by 5
Guimarães, R. A., Garcia, R. V., & Romão, E. C. (2021) · SUMA (Spanish Federation of Mathematics Teachers' Societies (FESPM)) · Cited by 5
Patterns of Symptom Reporting During Pregnancy Comparing Opioid Maintained and Control Women
Gordon, A. L., Lopatko, O. V., Stacey, H., Pearson, V., Woods, A., Fisk, A., & White, J. M. (2012) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31826b299d · Cited by 5
Buprenorphine in Maintenance Therapy
Phillips, K. A., & Preston, K. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6974-2_11 · Cited by 5
Singleton, R. J., Rutz, S., Day, G., Hammes, M., Wilson, A. S., Herrick, M., Mazut, C., Brunner, L., Prince, J., Desnoyers, C., et al. (2022) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000987 · Cited by 5
Buprenorphine reduces somatic withdrawal in a mouse model of early-life morphine exposure
Lepore, G. R., Morley-McLaughlin, T., Davidson, N., Han, C., Masese, C., Reynolds, G. F., Saltz, V., & Robinson, S. A. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109938 · Cited by 5
Neurobehavior of Neonates Born to Mothers Receiving Opioid Maintenance Treatment
Wouldes, T. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00058-5 · Cited by 5
Mental Health and Behavioral Disorders in Pregnancy
Wisner, K. L., Sit, D. K. Y., Bogen, D. L., Altemus, M. M., Pearlstein, T. B., Svikis, D. S., Misra, D. P., & Miller, E. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00055-x · Cited by 5
Willford, J. A., Smith, C., Kuhn, T., Weber, B. L., & Richardson, G. A. (2016) · InTech eBooks · doi:10.5772/63389 · Cited by 5
Second Trimester Pregnancy Loss
Casey, F. E. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.026 · Cited by 5
Konijnenberg, C., & Melinder, A. M. D. (2019) · Developmental Psychobiology · doi:10.1002/dev.21921 · Cited by 5
Nagpal, T. S., Bhattacharjee, J., da Silva, D. F., Souza, S. C. S., Mohammad, S., Puranda, J. L., Abu‐Dieh, A., Cook, J. L., & Adamo, K. B. (2020) · Birth Defects Research · doi:10.1002/bdr2.1803 · Cited by 5
Substances psychoactives pendant la grossesse ; quels effets chez l’enfant ?
Lejeune, C. (2014) · Revue de médecine périnatale · doi:10.1007/s12611-014-0288-2 · Cited by 5
Buprenorphine for opioid addiction
Ling, W. W., Mooney, L. J., & Torrington, M. (2013) · Neuropsychiatry · doi:10.2217/npy.13.47 · Cited by 5
Chavan, N. R., Ashford, K. B., Wiggins, A. T., Lofwall, M. R., & Critchfield, A. S. (2017) · American Journal of Perinatology Reports · doi:10.1055/s-0037-1608783 · Cited by 5
Research and policy priorities for addressing prenatal exposure to opioids in Alaska
Singleton, R. J., Slaunwhite, A., Herrick, M., Hirschfeld, M. J., Brunner, L., Hallas, C., Truit, S., Hanson, S. Z., Young, M. B., & Rider, E. D. (2019) · International Journal of Circumpolar Health · doi:10.1080/22423982.2019.1599275 · Cited by 5
Dash, S. K., Rahman, M. A., Yi, B., Williams, B., Lim, G., Zhou, S., Zou, P., Li, Y., Mahler, G. J., & Zhang, T. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.103767 · Cited by 4
Leech, A. A., Garbett, S. P., Yu, H. A., McNeer, E. A., Bharadwaj, R. R., Linas, B. P., Graves, J. A., Young, J. L., Su, L., Martin, P., et al. (2025) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2025.3067 · Cited by 4
Self-citationRichardson, L. M., Myers, A. M., Duran, J., Patel, D. N., Tran, K. L., Walsh, E. R., Perrine, S. A., Bowen, S. E., & Brummelte, S. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174112 · Cited by 4
Laptook, A. R., Czynski, A. J., Chahine, R. A., Greenberg, R. G., Smith, P. B., Oliveira, E., Gabrio, J. H., Eggleston, B. S., Das, A., Lee, J., et al. (2026) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2026.114992 · Cited by 4
Tabachnick, A. R., Eiden, R. D., Labella, M. H., & Dozier, M. (2023) · Psychophysiology · doi:10.1111/psyp.14470 · Cited by 4
Helou, N. E., Paul, R. A., Valentine, M. C., Raghuraman, N., Carter, E. B., Kelly, J. C., Friedman, H., & Stout, M. J. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100646 · Cited by 4
McNamara, K. A., Murnion, B. P., Fotheringham, P., Terplan, M., Lintzeris, N., Oei, J. L., Bond, D. M., Nassar, N., & Black, K. I. (2024) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2023-202140 · Cited by 4
Cambonie, G., Baron, L. A. D., Combes, C., Chanal, C., Mazurier, E., Toubin, R.-M., Fortier, M., Polito, A., Fuchs, F., & Gavotto, A. (2024) · Early Human Development · doi:10.1016/j.earlhumdev.2024.106132 · Cited by 4
Comments on: Efficacy versus Effectiveness of Buprenorphine and Methadone Maintenance in Pregnancy
Jones, H. E., Heil, S. H., Kaltenbach, K. A., Stine, S. M., Coyle, M. G., Arria, A. M., O’Grady, K. E., Selby, P. L., & Martin, P. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.736289 · Cited by 4
Self-citationThe Prescription Opioid Epidemic: Repercussions on Pediatric Emergency Medicine
Gugelmann, H. M., & Nelson, L. S. (2012) · Clinical Pediatric Emergency Medicine · doi:10.1016/j.cpem.2012.10.002 · Cited by 4
Thao, V., Enns, E. A., Patrick, S. W., Levy, R. J., & Kozhimannil, K. B. (2017) · Women s Health Issues · doi:10.1016/j.whi.2017.10.008 · Cited by 4
Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned
Gadomski, A., Riley, M. R., Ramiza, K., Onofrey, L. A., Zinkievich, R., Krupa, N. L., & Scribani, M. (2018) · Academic Pediatrics · doi:10.1016/j.acap.2018.02.006 · Cited by 4
Indicated Opioids in Pregnancy: Guidance on Providing Comprehensive Care
Cleary, E. M., Smid, M. C., Bokat, C. E., Costantine, M. M., & Rood, K. M. (2021) · American Journal of Perinatology · doi:10.1055/s-0041-1739427 · Cited by 4
Drugs and Environmental Agents in Pregnancy and Lactation
Niebyl, J. R., & Simpson, J. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00008-9 · Cited by 4
Maylott, S. E., Lester, B. M., Brown, L., Castano, A. J., Dansereau, L. M., Crowell, S. E., Deboeck, P. R., Salisbury, A. L., & Conradt, E. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306176 · Cited by 4
Humbarger, O., & Galanto, D. (2015) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000263 · Cited by 4
Farr, A., Kiss, H., Hagmann, M., Holzer, I., Kueronya, V., Husslein, P. W., & Petričević, L. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-1003-z · Cited by 4
Mian, P., Tibboel, D., Wildschut, E. D., van den Anker, J. N., & Allegaert, K. (2019) · Minerva Pediatrics · doi:10.23736/s0026-4946.17.04928-3 · Cited by 4
„Hot topics“ aus der geburtshilflichen Anästhesie
Brück, S., Annecke, T., Bremerich, D. H., Byhahn, C., Chappell, D., Kaufner, L., Schlösser, L., & Kranke, P. (2020) · Der Anaesthesist · doi:10.1007/s00101-019-00718-0 · Cited by 4
Courchesne‐Krak, N. S., & Meyers‐Pantele, S. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-33404-8_16 · Cited by 4
Addiction among women and sexual minority groups
Ait‐Daoud, N., Amin, P. A., & Bennett, A. H. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00028-x · Cited by 4
Using buprenorphine to treat neonatal abstinence syndrome: a quality improvement study
Bhandary, S., Lambeth, T., Holmes, A. P., & Pylipow, M. (2021) · Journal of Perinatology · doi:10.1038/s41372-021-01035-4 · Cited by 4
Peripartum management for women with opioid dependence
Shah, J., Ramseyer, A. M., & Coker, J. L. (2021) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000996 · Cited by 4
Opioid Use Treatment and Recovery Services During Pregnancy
Woods, L., & Connelly, C. D. (2021) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903211033033 · Cited by 4
Shaffer, S. K., & Stockdale, C. K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.033 · Cited by 4
County-level Factors and Treatment Access Among Insured Women With Opioid Use Disorder
Leech, A. A., McNeer, E. A., Stein, B. D., Richards, M. R., McElroy, T., Dupont, W. D., & Patrick, S. W. (2023) · Medical Care · doi:10.1097/mlr.0000000000001867 · Cited by 4
Raith, W., Resch, B., & Urlesberger, B. (2014) · Deutsche Zeitschrift für Akupunktur · doi:10.1016/j.dza.2014.07.003 · Cited by 4
Neonatal Withdrawal Syndrome, Michigan, 2000–2009
Hekman, K. A., Grigorescu, V. I., Cameron, L. L., Miller, C. E., & Smith, R. A. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2013.02.019 · Cited by 4
Effect of thienorphine on the isolated uterine strips from pregnant rats
Zhou, P., Yan, L., Yong, Z., Yu, G., Dong, H., Yan, H. M., Su, R., & Gong, Z. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.063 · Cited by 4
Standards for Opioid Treatment in the Criminal Justice System: Implications for Nurses
Chavez, S. R. (2012) · Journal of Addictions Nursing · doi:10.3109/10884602.2011.645256 · Cited by 4
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Stockman, J. A. (2012) · Yearbook of Pediatrics · doi:10.1016/j.yped.2011.04.036 · Cited by 4
Drugs and Environmental Agents in Pregnancy and Lactation
Niebyl, J. R., Weber, R. J., & BRIGGS, G. G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00008-1 · Cited by 4
Townsel, C., Odukoya, E. J., Rae, J. M., & Thomas, D. G. (2022) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.2022647 · Cited by 4
Fleites, V., Markwalter, P., Johnson, K., & Biasi, M. D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.28.482336 · Cited by 4
Systematic evidence review on methadone harms and comparative harms
Chou, R., Weimer, M. B., & Fiellin, D. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.02.113 · Cited by 3
The Impact of the Opioid Crisis on Neonates, Children, and Adolescents
Gaither, J. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-36287-4_2 · Cited by 3
Kumar, N., Rocha, F. G., Moustafa, A. S. Z., Masten, M., Bruder, A., Parmar, K., Adekola, H., Sampath, V., & Monga, R. (2021) · Journal of Neonatal-Perinatal Medicine · doi:10.3233/npm-200645 · Cited by 3
Following the Developing Brain Affected by Opioid Exposure
Madurai, N. K., & Jantzie, L. L. (2025) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2025.0274 · Cited by 3
Association between medication for opioid use disorder during pregnancy and neonatal outcomes
Hall, R. W., Babineau, D. C., Bangdiwala, A. S., Rhodes, E., Venable, T., Asher, C. C., Ambalavanan, N., Davis, J. M., Adeniyi-Jones, S. C., Leeman, L. M., et al. (2025) · Journal of Perinatology · doi:10.1038/s41372-025-02442-7 · Cited by 3
Medically Supervised Withdrawal for Opioid Dependence
Silverman, S. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1951-2_40 · Cited by 3
Mental Health and Behavioral Disorders in Pregnancy
Wisner, K. L., Sit, D. K. Y., Altemus, M. M., Bogen, D. L., Famy, C. S., Pearlstein, T. B., Misra, D. P., Reynolds, S. K., & Perel, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00052-1 · Cited by 3
Koppel, S., & Skolnick, P. (2017) · Journal of Drug Policy Analysis · doi:10.1515/jdpa-2017-0001 · Cited by 3
Induction and Augmentation of Labor
Goldberg, A. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316662571.004 · Cited by 3
Lu, D., Harmanjeet, H., Wanandy, T., Paine, M., Peterson, G. M., & Patel, R. P. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13008 · Cited by 3
A Family Guide to Coping with Substance Use Disorders
Daley, D. C., & Douaihy, A. B. (2019) · doi:10.1093/med-psych/9780190926632.001.0001 · Cited by 3
Parlett, L. E., Agiro, A., Brown, S. D., Wilt, M., Portzline, A., Verburg, J., Shea, K., & DEVRIES, A. R. (2019) · Medical Care · doi:10.1097/mlr.0000000000001199 · Cited by 3
Metadata
- Authors
- Jones, H. E., Kaltenbach, K., Heil, S. H., Stine, S. M., Coyle, M. G., Arria, A. M., O'Grady, K. E., Selby, P., Martin, P. R., & Fischer, G.
- Affiliations
- Johns Hopkins University (US)
- Thomas Jefferson University (US)
- University of Vermont (US)
- Wayne State University (US)
- Brown University (US)
- University of Maryland, College Park (US)
- University of Toronto (CA)
- Vanderbilt University (US)
- Medical University of Vienna (AT)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-12-09
- Volume
- 363
- Issue
- 24
- Pages
- 2320-2331
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3073631
- OpenAlex
- W2025988777
- Cited by
- 986
- References
- 41
- Citations by year
- 2026: 33 · 2025: 38 · 2024: 44 · 2023: 56 · 2022: 45 · 2021: 59 · 2020: 67 · 2019: 97 · 2018: 51 · 2017: 139 · 2016: 72 · 2015: 58 · 2014: 63 · 2013: 56 · 2012: 78
- FWCI
- 46.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA 017513, R01DA015764, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
- National Center for Research Resources (M01-RR-109, M01RR000095, M01-RR-00095)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- neonatal abstinence syndrome, methadone, buprenorphine, opioid dependence in pregnancy, prenatal opioid exposure, mu-opioid receptor agonists, neonatal hospital stay, neonatal head circumference
- MeSH terms
- Adult, Buprenorphine, Double-Blind Method, Female, Head, Humans, Infant, Newborn, Length of Stay, Methadone, Morphine, Opioid-Related Disorders, Narcotics, Neonatal Abstinence Syndrome, Pregnancy, Pregnancy Complications, Logistic Models, History, Ancient
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.